Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Patient's HLA Genotype Is Associated With the Risk of Central Nervous System Dissemination and Clinical Disease Presentation in Diffuse Large B-cell Lymphoma.

Anticancer research - 1 Aug 2024

Ollikainen Riina K, Sippola Antti, Turpeenniemi-Hujanen Taina, Kuitunen Hanne, Porvari Katja, Haapasaari Kirsi-Maria, Kuusisto Milla E L, Klaavuniemi Tuula, Kuittinen Outi

Abstract excerpt

BACKGROUND/AIM: Central nervous system (CNS) involvement in aggressive B-cell lymphoma, either as a primary or secondary event to systemic disease, portends a poor prognosis. This study sought to identify patients at high risk for CNS relapse by analyzing their human leukocyte antigen (HLA) genotypes. PATIENTS AND METHODS: We retrospectively examined the HLA genotypes of 164 patients with systemic lymphoma,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Central Nervous System Neoplasms

Share to HLA Antigens

Share to Lymphoma, Large B-Cell, Diffuse

Share to Prognosis

Share to Risk Factors

Share to Young Adult

Source

Identifiers

PMID: 39060054
DOI: 10.21873/anticanres.17143

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Patient's HLA Genotype Is Associated With the Risk of Central Nervous System Dissemination and Clinical Disease Presentation in Diffuse Large B-cell Lymphoma.PMID 39060054Read ↗

Specific KIR-HLA genotypes predict outcomes in refractory or relapsed primary central nervous system lymphoma.Semantic proximity Read ↗

Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.Semantic proximity Read ↗

Specific KIR-HLA genotypes predict the outcomes of refractory or recurrent primary central nervous system lymphomaSemantic proximity Read ↗

Primary CNS lymphoma and HLA class I and II alleles in a German cohort of immunocompetent patients.Semantic proximity Read ↗

Specific KIR-HLA genotypes predict outcomes of refractory or recurrent primary central nervous system lymphomaSemantic proximity Read ↗

HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma.Semantic proximity Read ↗

Genetic predisposition to autoimmune encephalitis and paraneoplastic neurological syndromes.Semantic proximity Read ↗

Human leukocyte antigen-G polymorphisms influence the clinical outcome in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Human leukocyte antigen distribution analysis in North Italian brain Glioma patients: an association with HLA-DRB1*14.Semantic proximity Read ↗

HLA-B*35 as a new marker for susceptibility to Human T-cell Lymphotropic Virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in ArgentinaSemantic proximity Read ↗

Germline HLA-DQ genotype influences response to CAR T-cell therapy in patients with large B-cell lymphomaSemantic proximity Read ↗

Homozygous FCGR3A-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.